Assistant Professor | Central south university, China
Maonan Wang is an Assistant Professor at the Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, China. He holds a Ph.D. from Southeast University and completed a Joint-Ph.D. at the National University of Singapore. His research focuses on nanomedicine, tumor immunotherapy, and biomaterials for cancer treatment. Wang has published extensively in high-impact journals, contributing to advances in cancer diagnostics and therapeutics. His work involves innovative nano-delivery systems and biosynthesized nanomaterials. He has received multiple research accolades and actively collaborates on interdisciplinary biomedical projects.
Profile
Scopus
🎓 Education
Ph.D., Southeast University (2018-2022). Joint-Ph.D., National University of Singapore, Chemical and Biomolecular Engineering (2021-2022). M.D., Central South University (2015-2018). B.D., Changzhi Medical College (2011-2015). Currently serving as an Assistant Professor at Central South University since August 2022.
💼 Experience
Assistant Professor, Central South University (2022-Present). Researcher, National University of Singapore (2021-2022). Ph.D. Researcher, Southeast University (2018-2022). Extensive experience in nanomedicine, cancer therapy, and biomaterials research. Collaborated on multiple interdisciplinary projects in pathology and biomedical engineering
🏆 Awards & Honors
Published in top journals like PNAS, Bioactive Materials, Nano Today, Coordination Chemistry Reviews. Recognized for groundbreaking work in nano-delivery systems and cancer therapeutics. Received multiple research grants and fellowships for contributions to biomedicine. Acknowledged for excellence in interdisciplinary biomedical research and innovation
🔬 Research Focus
Nanomedicine and cancer immunotherapy. Tumor-targeted drug delivery and nano-biomaterials. Biosynthesized nanoparticles for therapeutic applications. Photothermal PCR and rapid nucleic acid detection. Exploring tumor microenvironment and immune evasion mechanisms
🔹 Conclusion
Maonan Wang is a strong candidate for the Best Researcher Award, given his high-impact publications, interdisciplinary expertise, and contributions to biomedical nanotechnology and cancer therapy. Strengthening his profile with grants, mentorship roles, and translational research impact could further bolster his competitiveness. 🚀
Publication
-
Title: In situ self-assembling Au-DNA complexes for targeted cancer bioimaging and inhibition
Year: 2020
Author: Maonan Wang, Yun Chen, Weijuan Cai, Huan Feng, Tianyu Du, Weiwei Liu, Hui Jiang, Alberto Pasquarelli, Yossi Weizmann*, Xuemei Wang*
Citation: PNAS, 117: 308 (IF=11.1)
-
Title: Baiting bacteria with amino acidic and peptidic corona coated defect-engineered antimicrobial nanoclusters for optimized wound healing
Year: 2024
Author: Maonan Wang†, Houjuan Zhu†, Yuling Xue, Yanxia Duan, Hua Tian, Qi Liu, Yuzhu Zhang, Zibiao Li, Xian Jun Loh, Enyi Ye, Gang Yin, Xuemei Wang, Xianguang Ding, David Tai Leong*
Citation: Bioactive Materials, 42: 628-643 (IF=18)
-
Title: An ultrafast and portable nucleic acid detection system based on photothermal PCR and real-time fluorescence detection
Year: 2023
Author: Liangxi Zhu, Jingzhou Zhao, Yile Fang, Zhukang Guo, Maonan Wang*, Nongyue He*
Citation: Nano Today, 53: 102019 (IF=13.2)
-
Title: Advance of nano anticancer therapies targeted on tumor-associated macrophages
Year: 2021
Author: Maonan Wang, Jingzhou Zhao, Hongjie Xiong, Hongbing Lu, Hui Jiang, Xuemei Wang*
Citation: Coordination Chemistry Reviews, 446: 214126 (IF=20.6)
-
Title: Tumor targeted nano-delivery system of therapeutic RNA
Year: 2022
Author: Maonan Wang, Jingzhou Zhao, Hui Jiang, Xuemei Wang*
Citation: Materials Horizons, 9: 1111-1140 (IF=13.3)
-
Title: Bio-assembled smart nanocapsules for targeted delivery of KRAS shRNA and cancer cell bioimage
Year: 2023
Author: Maonan Wang, Zengchao Guo, Jiayu Zeng, Liu Liu, Yihan Wang, Jinpeng Wang, Hongbing Lu, Haijun Zhang, Hui Jiang, Xuemei Wang*
Citation: Chinese Chemical Letters, 34: 107651 (IF=9.1)
-
Title: In situ biosynthesized gold nanoclusters inhibiting cancer development via the PI3K–AKT signaling Pathway
Year: 2019
Author: Maonan Wang†, Zeqian Yu†, Huan Feng, Jianling Wang, Lishan Wang, Yu Zhang, Lihong Yin, Ying Du, Hui Jiang, Xuemei Wang*, Jiahua Zhou*
Citation: Journal of Materials Chemistry B, 7(35): 5336-5344 (IF=7.57)
-
Title: Biophysics involved in the process of tumor immune escape
Year: 2022
Author: Maonan Wang, Hui Jiang, Xiaohui Liu*, Xuemei Wang*
Citation: iScience, 25: 104124 (IF=5.8)
-
Title: The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway
Year: 2021
Author: Maonan Wang†, Manli Dai†, Dan Wang†, Ting Tang, Fang Xiong, Bo Xiang, Ming Zhou, Xiaoling Li, Yong Li, Wei Xiong, Guiyuan Li, Zhaoyang Zeng*, Can Guo*
Citation: Cancer Letters, 512: 60-72 (IF=9.7)
-
Title: The regulatory networks of the Hippo signaling pathway
Year: 2021
Author: Maonan Wang, Manli Dai, Dan Wang, Wei Xiong, Zhaoyang Zeng*, Can Guo*
Citation: Journal of Cancer, 12(20): 6216-6230 (IF=3.9)
-
Title: Additive Manufacturing in Orthopedics: A Review
Year: 2022
Author: Yingchao Zhao, Zhen Wang, Jingzhou Zhao, Mubashir Hussain, Maonan Wang*
Citation: ACS Biomaterials Science & Engineering, 8(4): 1367-1380 (IF=5.7)